Pattern of miR-155 and PU.1 expression in CLL/SLL and aggressive lymphomas
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26424991%3A_____%2F11%3A%230000012" target="_blank" >RIV/26424991:_____/11:#0000012 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pattern of miR-155 and PU.1 expression in CLL/SLL and aggressive lymphomas
Original language description
We herein found the increased levels of miR-155 coupled with downregulation of its target PU.1 are frequent events in B cells of a vast majority of CLL patients (N=169). To advance understanding of miR-155 and PU.1 in lymphoid malignancies we studied lymph node biopsies derived from patients with lymphomas. We show that increased miR-155 levels are also found in DLBCL (N=31, P < 0.0001), Hodgkin lymphoma (HL, N=22, P < 0.0001), follicular lymphoma (FL, N=23, P < 0.001), small lymphocytic lymphoma (SLL,N=12, P < 0.01), and marginal zone lymphoma (MZL, N=11, P < 0.01).
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/FR-TI2%2F509" target="_blank" >FR-TI2/509: *Development of kit for testing molecular effects of anti-tumor drugs on chromatin structure</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Blood
ISSN
0006-4971
e-ISSN
—
Volume of the periodical
118
Issue of the periodical within the volume
21
Country of publishing house
US - UNITED STATES
Number of pages
1
Pages from-to
4600
UT code for WoS article
—
EID of the result in the Scopus database
—